US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist

1.2483
-0.0517-3.98%

Trading Aug 14 13:23 ET

156.98MMarket Cap-5944P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-1.48%-4.53M

33.10%-4.7M

-0.87%-20.94M

-23.17%-5.57M

28.23%-3.88M

24.95%-4.47M

-43.95%-7.02M

-26.03%-20.76M

-23.41%-4.52M

-76.68%-5.41M

Net income from continuing operations

38.46%-6.05M

6.42%-5.88M

-11.62%-30.09M

-3.51%-7.75M

22.25%-6.23M

-47.35%-9.83M

-31.24%-6.28M

-30.84%-26.96M

-55.03%-7.49M

-54.17%-8.01M

Operating gains losses

--2K

----

--3K

--0

--2K

Depreciation and amortization

33.33%4K

66.67%5K

187.50%23K

600.00%14K

50.00%3K

-65.22%8K

0.00%2K

-66.67%2K

Change In working capital

50.85%1.16M

132.63%756K

353.59%1.52M

16.12%1.65M

52.04%1.42M

173.10%769K

-21.95%-2.32M

48.18%-599K

413.00%1.42M

178.21%932K

-Change in receivables

----

125.84%743K

121.05%28K

----

175.29%329K

2.92%-133K

345.76%290K

-Change in prepaid assets

132.73%903K

116.99%664K

201.15%2.81M

1,558.44%2.25M

-168.53%-135K

127.13%388K

122.08%306K

-311.42%-2.77M

74.55%-154K

-61.30%197K

-Change in payables and accrued expense

-0.25%400K

102.58%69K

-186.58%-2.12M

-99.63%10K

115.54%143K

-72.38%401K

-235.43%-2.67M

432.46%2.44M

86.89%2.71M

-707.02%-920K

-Change in other current assets

-11,000.00%-111K

--0

-184.25%-1.7M

-143.55%-2.42M

-47.48%719K

99.88%-1K

100.88%1K

-14.59%-597K

14.78%-992K

2,144.26%1.37M

-Change in other current liabilities

-68.42%-32K

-50.00%23K

89,300.00%1.78M

22,375.00%1.78M

-525.00%-25K

-205.56%-19K

675.00%46K

-111.76%-2K

-366.67%-8K

-33.33%-4K

Cash from discontinued investing activities

Operating cash flow

-1.48%-4.53M

33.10%-4.7M

-0.87%-20.94M

-23.17%-5.57M

28.23%-3.88M

24.95%-4.47M

-43.95%-7.02M

-26.03%-20.76M

-23.41%-4.52M

-76.68%-5.41M

Investing cash flow

Cash flow from continuing investing activities

76.92%-3K

-6K

99.70%-14K

99.96%-1K

-13K

-52,422.22%-4.73M

-2.01M

-29,966.67%-2.71M

Net PPE purchase and sale

76.92%-3K

---6K

48.15%-14K

--0

83.33%-1K

---13K

--0

-200.00%-27K

---8K

33.33%-6K

Net investment purchase and sale

----

--0

----

---4.7M

---2M

----

Cash from discontinued investing activities

Investing cash flow

76.92%-3K

---6K

99.70%-14K

--0

99.96%-1K

---13K

--0

-52,422.22%-4.73M

---2.01M

-29,966.67%-2.71M

Financing cash flow

Cash flow from continuing financing activities

100K

204K

-1.48M

Net common stock issuance

----

---1.48M

--0

----

--0

----

Proceeds from stock option exercised by employees

--100K

--204K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--100K

--204K

---1.48M

--0

---1.48M

--0

Net cash flow

Beginning cash position

-19.15%84.07M

-20.21%88.57M

-18.67%111M

-19.86%94.14M

-20.81%99.5M

-20.99%103.98M

-18.67%111M

244.11%136.49M

-16.18%117.48M

-11.85%125.65M

Current changes in cash

0.98%-4.43M

35.92%-4.5M

11.99%-22.43M

14.70%-5.57M

33.97%-5.36M

24.73%-4.48M

-43.57%-7.02M

-126.32%-25.49M

-78.25%-6.53M

-239.30%-8.12M

End cash Position

-19.96%79.64M

-19.15%84.07M

-20.21%88.57M

-19.86%94.14M

-20.81%99.5M

-20.99%103.98M

-18.67%111M

-16.18%117.48M

Free cash flow

-1.25%-4.53M

33.01%-4.7M

-0.81%-20.96M

-22.95%-5.57M

28.29%-3.88M

24.73%-4.48M

-43.57%-7.02M

-26.13%-20.79M

-23.63%-4.53M

-76.36%-5.42M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-1.48%-4.53M	33.10%-4.7M	-0.87%-20.94M	-23.17%-5.57M	28.23%-3.88M	24.95%-4.47M	-43.95%-7.02M	-26.03%-20.76M	-23.41%-4.52M	-76.68%-5.41M
Net income from continuing operations	38.46%-6.05M	6.42%-5.88M	-11.62%-30.09M	-3.51%-7.75M	22.25%-6.23M	-47.35%-9.83M	-31.24%-6.28M	-30.84%-26.96M	-55.03%-7.49M	-54.17%-8.01M
Operating gains losses	--2K	--2K	----	----	----	----	----	--3K	--0	--2K
Depreciation and amortization	33.33%4K	66.67%5K	187.50%23K	600.00%14K	50.00%3K	50.00%3K	50.00%3K	-65.22%8K	0.00%2K	-66.67%2K
Change In working capital	50.85%1.16M	132.63%756K	353.59%1.52M	16.12%1.65M	52.04%1.42M	173.10%769K	-21.95%-2.32M	48.18%-599K	413.00%1.42M	178.21%932K
-Change in receivables	----	----	125.84%743K	121.05%28K	----	----	----	175.29%329K	2.92%-133K	345.76%290K
-Change in prepaid assets	132.73%903K	116.99%664K	201.15%2.81M	1,558.44%2.25M	-168.53%-135K	127.13%388K	122.08%306K	-311.42%-2.77M	74.55%-154K	-61.30%197K
-Change in payables and accrued expense	-0.25%400K	102.58%69K	-186.58%-2.12M	-99.63%10K	115.54%143K	-72.38%401K	-235.43%-2.67M	432.46%2.44M	86.89%2.71M	-707.02%-920K
-Change in other current assets	-11,000.00%-111K	--0	-184.25%-1.7M	-143.55%-2.42M	-47.48%719K	99.88%-1K	100.88%1K	-14.59%-597K	14.78%-992K	2,144.26%1.37M
-Change in other current liabilities	-68.42%-32K	-50.00%23K	89,300.00%1.78M	22,375.00%1.78M	-525.00%-25K	-205.56%-19K	675.00%46K	-111.76%-2K	-366.67%-8K	-33.33%-4K
Cash from discontinued investing activities
Operating cash flow	-1.48%-4.53M	33.10%-4.7M	-0.87%-20.94M	-23.17%-5.57M	28.23%-3.88M	24.95%-4.47M	-43.95%-7.02M	-26.03%-20.76M	-23.41%-4.52M	-76.68%-5.41M
Investing cash flow
Cash flow from continuing investing activities	76.92%-3K	-6K	99.70%-14K	0	99.96%-1K	-13K	0	-52,422.22%-4.73M	-2.01M	-29,966.67%-2.71M
Net PPE purchase and sale	76.92%-3K	---6K	48.15%-14K	--0	83.33%-1K	---13K	--0	-200.00%-27K	---8K	33.33%-6K
Net investment purchase and sale	----	----	--0	--0	----	----	----	---4.7M	---2M	----
Cash from discontinued investing activities
Investing cash flow	76.92%-3K	---6K	99.70%-14K	--0	99.96%-1K	---13K	--0	-52,422.22%-4.73M	---2.01M	-29,966.67%-2.71M
Financing cash flow
Cash flow from continuing financing activities	100K	204K	-1.48M	0	-1.48M	0	0	0	0
Net common stock issuance	----	----	---1.48M	--0	----	----	----	--0	--0	----
Proceeds from stock option exercised by employees	--100K	--204K	----	----	----	--0	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	--100K	--204K	---1.48M	--0	---1.48M	--0	--0	--0	--0	--0
Net cash flow
Beginning cash position	-19.15%84.07M	-20.21%88.57M	-18.67%111M	-19.86%94.14M	-20.81%99.5M	-20.99%103.98M	-18.67%111M	244.11%136.49M	-16.18%117.48M	-11.85%125.65M
Current changes in cash	0.98%-4.43M	35.92%-4.5M	11.99%-22.43M	14.70%-5.57M	33.97%-5.36M	24.73%-4.48M	-43.57%-7.02M	-126.32%-25.49M	-78.25%-6.53M	-239.30%-8.12M
End cash Position	-19.96%79.64M	-19.15%84.07M	-20.21%88.57M	-20.21%88.57M	-19.86%94.14M	-20.81%99.5M	-20.99%103.98M	-18.67%111M	-18.67%111M	-16.18%117.48M
Free cash flow	-1.25%-4.53M	33.01%-4.7M	-0.81%-20.96M	-22.95%-5.57M	28.29%-3.88M	24.73%-4.48M	-43.57%-7.02M	-26.13%-20.79M	-23.63%-4.53M	-76.36%-5.42M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall